These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8758481)

  • 41. [Lipid vehicles for the parenteral administration of drugs (1): emulsions].
    Bermejo Vicedo T; Hidalgo Correas FJ; Carrasco JM
    Nutr Hosp; 1996; 11(1):7-16. PubMed ID: 8704021
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A study of the stability of lipid emulsions in mixtures for peripheral parenteral nutrition].
    Selva Otaolaurruchi J; Ruiz López I; Marco Garbayo JL; Burgos San José A; Provencio Arranz RM
    Nutr Hosp; 1989; 4(3):154-7. PubMed ID: 2485366
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The use of commercially available lipid emulsions for the preparation of amphotericin B-lipid admixtures.
    Shadkhan Y; Segal E; Bor A; Gov Y; Rubin M; Lichtenberg D
    J Antimicrob Chemother; 1997 May; 39(5):655-8. PubMed ID: 9184368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Amphotericin B and lipids: a new formulation].
    Ordóñez J; García A; Ferrándiz R
    Nutr Hosp; 1994; 9(2):114-5. PubMed ID: 8031949
    [No Abstract]   [Full Text] [Related]  

  • 45. Amphotericin B/emulsion admixture interactions: an approach concerning the reduction of amphotericin B toxicity.
    Egito ES; Araújo IB; Damasceno BP; Price JC
    J Pharm Sci; 2002 Nov; 91(11):2354-66. PubMed ID: 12379920
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lipid-based formulations of amphotericin B.
    Swenson CE; Bolcsak LE; Perkins WR; Janoff AS
    J Antimicrob Chemother; 1995 May; 35(5):709-13. PubMed ID: 7592188
    [No Abstract]   [Full Text] [Related]  

  • 47. Amphotericin B does not mix with fat emulsion.
    Trissel LA
    Am J Health Syst Pharm; 1995 Jul; 52(13):1463-4. PubMed ID: 7671046
    [No Abstract]   [Full Text] [Related]  

  • 48. Safety and efficacy of Intralipid emulsions of amphotericin B.
    Sievers TM; Kubak BM; Wong-Beringer A
    J Antimicrob Chemother; 1996 Sep; 38(3):333-47. PubMed ID: 8889711
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comment: expense of amphotericin B product.
    Andersen JM
    Ann Pharmacother; 1996 Nov; 30(11):1342. PubMed ID: 8913426
    [No Abstract]   [Full Text] [Related]  

  • 50. SolEmuls technology: a way to overcome the drawback of parenteral administration of insoluble drugs.
    Junghanns JU; Buttle I; Müller RH; Araújo IB; Silva AK; Egito ES; Damasceno BP
    Pharm Dev Technol; 2007; 12(5):437-45. PubMed ID: 17963143
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of lipid emulsions for the i.v. administration of a new water soluble polyene antibiotic, SPK-843.
    Mozzi G; Benelli P; Bruzzese T; Galmozzi MR; Bonabello A
    J Antimicrob Chemother; 2002 Feb; 49(2):321-5. PubMed ID: 11815574
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Physicochemical properties of parenteral fat emulsions containing 20% triglyceride; Intralipid and Ivelip.
    Washington C; Koosha F; Davis SS
    J Clin Pharm Ther; 1993 Apr; 18(2):123-31. PubMed ID: 8458880
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The oral delivery of amphotericin B.
    Torrado JJ; Serrano DR; Uchegbu IF
    Ther Deliv; 2013 Jan; 4(1):9-12. PubMed ID: 23401912
    [No Abstract]   [Full Text] [Related]  

  • 54. Administration of amphotericin B in lipid emulsion.
    O'Neil MG; Lapointe M
    Crit Care Med; 1997 May; 25(5):892-3; author reply 893-4. PubMed ID: 9187614
    [No Abstract]   [Full Text] [Related]  

  • 55. Administration of amphotericin B in lipid emulsion.
    Devlin J; Bailey E; Zarowitz B
    Crit Care Med; 1997 May; 25(5):892; author reply 893-4. PubMed ID: 9187613
    [No Abstract]   [Full Text] [Related]  

  • 56. Amphotericin B is incompatible with lipid emulsions.
    Ericsson O; Hallmen AC; Wikstrom I
    Ann Pharmacother; 1996 Mar; 30(3):298. PubMed ID: 8833570
    [No Abstract]   [Full Text] [Related]  

  • 57. Physicochemical properties of parenteral fat emulsions containing 20% triglyceride; Intralipid and Ivélip.
    Barnett MI; Cosslett AG
    J Clin Pharm Ther; 1994 Feb; 19(1):65-7. PubMed ID: 8188794
    [No Abstract]   [Full Text] [Related]  

  • 58. [The stability of PN mixtures and their compatibility with drugs].
    Figueras i Felip J; Torrejón i Mir J
    Nutr Hosp; 1989; 4(1):6-11. PubMed ID: 2485343
    [No Abstract]   [Full Text] [Related]  

  • 59. A study of the solubility of amphotericin B in nonaqueous solvent systems.
    Rajagopalan N; Dicken CM; Ravin LJ; Sternson LA
    J Parenter Sci Technol; 1988; 42(3):97-102. PubMed ID: 3216269
    [No Abstract]   [Full Text] [Related]  

  • 60. Long-term intravenous drug therapy.
    Stamm AM
    Arch Intern Med; 1980 Jul; 140(7):987. PubMed ID: 7387312
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.